QualityStocksNewsBreaks Archives - Page 671 of 1387

MondayApr 19, 2021 12:58 pm

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Announces FY2020 Business, Financial Results

Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has released its 2020 financial results and has filed its annual report for the fiscal year ended Dec. 31, 2020. Company highlights include bringing the production of NeuroCaps(TM) to the United States; launching the commercial roll-out of its NeuroEEG(TM) and NeuroCap(TM) on a limited basis in the United States market; establishing wholly owned subsidiaries in Russia and Poland; and a significant increase in research and development efforts. Furthermore, the company announced that it has filed a provisional patent application for a new long-term monitoring EEG cap; in addition, its proprietary NeuroCap is…

MondayApr 19, 2021 12:49 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Establishes Clinical Advisory Board, to Present at Bloom Burton & Co. Health Care Investor Conference

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced the formation of its clinical advisory board. Additions to the board include Maurizio Fava, MD, psychiatrist-in-chief in the Department of Psychiatry at Massachusetts General Hospital, Lynn Marie Morski, MD, Esq., president of the Psychedelic Medicine Association, and Anthony Back, MD, professor in the Department of Medicine and Division of Oncology at the University of Washington. Alex Belser, PhD, Cybin’s chief clinical officer, will chair the clinical advisory board. “We are delighted to welcome three accomplished experts in their respective fields to guide the strategic development…

MondayApr 19, 2021 11:35 am

QualityStocksNewsBreaks – AmpliTech Group Inc. (NASDAQ: AMPG) Closes on Registered Direct Offering, Gross Proceeds Total Estimated $23M

AmpliTech Group (NASDAQ: AMPG, AMPGW), a designer, developer and manufacturer of custom and standard state-of-the-art RF (“RF”) components for commercial, SATCOM, 5G, quantum computing, space, defense and military markets, has closed on its registered direct offering. The offering comprised 2,715,000 shares of common stock priced at-the-market under Nasdaq rules. In addition to its common stock, the company also issued warrants enabling investors to purchase up to 1,900,500 additional shares of common stock at $8.48 per share with a five-year term in a concurrent private placement. The announcement noted that gross proceeds from the direct offering totaled approximately $23 million before deducting typical…

MondayApr 19, 2021 11:02 am

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) Releases Statement Confirming Company in ‘Strongest Position’ Ever

HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, recently reassured investors that the company is moving forward and that all aspects of the company are sound. HempFusion made the announcement in response to recent trading activity that saw its share prices fall. The company stated that its material contracts and relationships with key distributors around the world are in good standing and that all aspects of the business, including the five-channel distribution strategy, are in-motion, with no undisclosed events that would cause the share decline. All…

MondayApr 19, 2021 10:53 am

QualityStocksNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Applies to List Shares on NASDAQ, Is Uplisting to NEO

Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), an investment company, has submitted an application to list its common shares on the NASDAQ Capital Market. The strategic move is designed to provide further opportunities to attract institutional and retail investors, thereby allowing the company to increase its investor base both in the United States and around the world. The move is also meant to increase visibility of the company’s growth strategy, accomplishments and results to date. The company also hopes to see increased liquidity of its common share and an enhanced overall profile, which will ultimately raise shareholder value.…

MondayApr 19, 2021 10:19 am

QualityStocksNewsBreaks – TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Announces $1M Order for Flagship Product

TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) has received a $1 million warehouse order for its TAAT(TM) Original, Smooth and Menthol nicotine-free, tobacco-free cigarette alternative. The order was placed by Worldwide Vape Distribution (“WWV”), a distribution company with access to more than 10,000 retail stores across 38 states. The order will be fulfilled in several batches throughout 2021 and will initially be shipped to the WWV warehouse in Dallas. WWV has positioned itself in the alternative tobacco category, boasting a strong portfolio of companies that manufacture hardware and supplies for electronic cigarettes. TAAT and WWV first signed…

FridayApr 16, 2021 2:14 pm

QualityStocksNewsBreaks – RYAH Group Inc.’s Products Facilitate Personalized Therapies, Remote Patient Monitoring

RYAH Group, a company developing proprietary technology supporting a data-driven approach to health care, has created a range of smart devices set to disrupt the future of medicine. RYAH Group, which is on a mission to advance the world’s transition to remote-health solutions, has done precisely that with its remote health platform called RYAH MD. “RYAH MD is a service that allows clinicians to remotely monitor and control patients’ dosing regimens with RYAH’s dose-measuring products. It provides necessary information that doctors can analyze to learn how different dosing variables affect outcomes. RYAH MD allows the doctor to recommend parameters on…

FridayApr 16, 2021 2:06 pm

QualityStocksNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Finalizes Move into US Cannabis Market

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), an innovative genetics-based cannabis company located in Canada, has closed a purchase agreement with the shareholders of Lords of Grasstown Holdings Ltd. in which PACR will acquire all the issued and outstanding shares. Under the arrangement, Pac Roots agreed to pay $50,000 in cash, within 30 days of the closing date, and issue 6 million common shares of the company. Lords of Grasstown traces its origin to the vision of Tyler Hazelwood, the founder and director of the iconic Lords of Gastown brand. “This acquisition marks a major milestone for the company…

FridayApr 16, 2021 1:48 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Offers Innovative Solution in Multibillion and Growing Market

Predictive Oncology (NASDAQ: POAI), through its Skyline Medical division, is positioned for opportunity in the fluid management systems and accessories market, which is projected to reach $16.1 billion in 2025 from $8.5 billion in 2020, expanding at a CAGR of 13.6%. These figures are according MarketsandMarkets, which cites several growth factors including technological advancements in fluid management systems (https://ibn.fm/rKWZC). As disposal of waste fluids presents a unique set of challenges for every health care facility, Skyline Medical offers a clear solution. Skyline’s patented and FDA-cleared STREAMWAY System is “the new standard in waste fluid management,” automating the collection, measurement and…

FridayApr 16, 2021 1:15 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) WP1244 Potentially 500X More Potent than Daunorubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company whose lead drug candidate Berubicin has yielded promising results in the treatment of glioblastoma multiforme (“GBM”), has made equally significant strides with its second drug candidate, WP1244. Still currently in development, preclinical work for WP1244 is expected to continue during 2021 and 2022. “WP1244 is a DNA-binding agent believed to be 500-times more potent than daunorubicin in inhibiting tumor cell proliferation,” reads a recent article. “The current target indication for WP1244 includes brain cancers, pancreatic cancers, ovarian cancers and lymphoma. Preclinical studies show high uptake in the brain with antitumor activity.” On the…

Site Search

Company Search

Category: QualityStocksNewsBreaks